SCHEMBL2840864

SCHEMBL2840864

Cc1cc2c(s1)CN(C)CCC2Oc1ccc2ccccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
FPR2 P25090 2/20 0.36
PROKR1 Q8TCW9 2/20 0.36
HRH3 Q9Y5N1 5/20 0.36
DRD3 P35462 1/20 0.36
CHRNA3 P32297 1/20 0.36
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
HPGD P15428 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
PDE10A Q9Y233 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2835662 0.84 CHRNA3 (0.32) KMT2AMEN1ALDH1A1CHRNA3
SCHEMBL2838989 0.84 FPR2 (0.37) KDM4EALDH1A1FPR2PROKR1CHRNA3
Hydrochloric Acid SCHEMBL2842454 0.83 FPR2 (0.36) KDM4EALDH1A1FPR2PROKR1CHRNA3
Hydrochloric Acid SCHEMBL2842024 0.83 SIGMAR1 (0.32) KMT2AMEN1ALDH1A1CHRNA3
SCHEMBL2840628 0.82 HCRTR1 (0.36) KMT2AMEN1HRH3RAB9APDE3B
Hydrochloric Acid SCHEMBL2841547 0.81 MEN1 (0.37) KMT2AMEN1HRH3RAB9APDE3B
Hydrochloric Acid SCHEMBL3579033 0.80 MCHR1 (0.39) KDM4EALDH1A1MAPTSMN1; SMN2FPR2
SCHEMBL2844034 0.80 PARP10 (0.41) KMT2AMEN1HRH3NPC1RAB9A
SCHEMBL2837859 0.79 SSTR1 (0.36) KMT2AKDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL2837102 0.77 PKM (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 KMT2A 1371/4885KDM4E 3292/4885MEN1 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.